U.S. Case Report of Cerebral Phaeohyphomycosis Caused byRamichloridium obovoideum (R. mackenziei): Criteria for Identification, Therapy, and Review of Other Known Dematiaceous Neurotropic Taxa
- 1 March 1998
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (3) , 708-715
- https://doi.org/10.1128/jcm.36.3.708-715.1998
Abstract
We report a case of cerebral phaeohyphomycosis in a 36-year-old male caused by the neurotropic fungusRamichloridium obovoideum(Matushima) de Hoog 1977 (Ramichloridium mackenzieiCampbell et Al-Hedaithy 1993). This man resided in the Middle East, where the fungus appears to be endemic and, possibly, geographically restricted, since all previous reports of brain abscesses due to this organism have been for patients indigenous to this area. As a servant of the Saudi Arabian royal family, he appeared in the United States seeking treatment for chronic weight loss, fatigue, decreased memory, and a more recent 2-week history of right-hand weakness which worsened to involve the entire right upper extremity. On the day prior to his admission, he had a focal motor seizure with rotation of the head and eyes to the right, followed by secondary generalization. A computerized tomogram showed a ring-enhancing hypodense lesion in the left parietal subcortical region with associated edema and mass effect. Diagnosis of a fungal etiology was made following a parietal craniotomy and excisional biopsy by observation of septate, dematiaceous hyphal elements 2 to 3 μm in width on hematoxylin-and-eosin-stained sections from within areas of inflammation and necrosis. Culture of the excised material grew out a dematiaceous mould which was subsequently identified asR. obovoideum. At two months postsurgery and with a regimen of 200 mg of itraconazole twice a day, the patient was doing well and returned to Saudi Arabia. His condition subsequently deteriorated, however, and following a 7-month course of itraconzole, he expired. We use this case to alert clinicians and personnel in clinical mycology laboratories of the pathogenicity of this organism and its potential occurrence in patients with central nervous system signs and symptoms who have resided in the Middle East and to review and/or compareR. obovoideumwith other neurotropic, dematiaceous taxa and similar nonneurotropic, dematiaceous species.Keywords
This publication has 46 references indexed in Scilit:
- Successful Treatment of Systemic Exophiala dermatitidis Infection in a Patient with Chronic Granulomatous DiseaseClinical Infectious Diseases, 1992
- Cerebral phaeohyphomycosis caused byXylohypha bantianaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Comparative Histopathology of Dactylaria constricta, Fonsecaea pedrosoi, Wangiella dermatitidis, and Xylohypha bantiana in Experimental Phaeohyphomycosis of the Central Nervous System.Mycoses, 1987
- In vitro and in vivo Drug Studies with Three Agents of Central Nervous System PhaeohyphomycosisChemotherapy, 1987
- Phaeohyphomycosis complicating compound skull fractureSurgical Neurology, 1986
- Ramichloridium, Veronaea and Stenella: Generic delimitation, new combinations and two new speciesTransactions of the British Mycological Society, 1983
- Chromomycosis in JapanInternational Journal of Dermatology, 1983
- Pulmonary and cerebral mycetoma caused by Curvularia pallescensThe Journal of Pediatrics, 1977
- Cerebral chromoblastomycosisJournal of Neurosurgery, 1971
- BRAIN ABSCESS DUE TO HORMODENDRUM DERMATITIDIS (KANO) CONANT, 1953 —Report of a Case and Review of the Literature—Psychiatry and Clinical Neurosciences, 1963